566th MEETING, CAMBRIDGE 139 latter analogue on shape-change and aggregation induced by ADP, and on aggregation induced by adrenaline are qualitatively similar to those described above for o-ADP.
Singlet oxygen, released on photo-activation of certain porphyrins, was found to be a potent inhibitor of growth of experimental tumours in vivo (Dougherty et al., 1975) and in vitro (Dougherty et al., 1976) . Many biological materials are known to interact with the singlet-oxygen intermediate (Spikes, 1975) . In thepresent work, I have investigatedeffects of photo-activated porphyrins on mouse leukaemia L1210 cells in culture, to identify early effects of singlet-oxygen toxicity.
Studies of transport of nucleosides (uridine, thymidine) and a model amino acid (cycloleucine) were performed as described before (Kessel & Dodd, 1972) . The most potent porphyrin examined was deuteroporphyrin IX; in light a 1Omin exposure of L1210 cells to this compound ( 3~1~) subsequently impaired nucleoside and amino acid transport by 50%. We found no evidence of inhibition of incorporation of precursors (uridine, thymidine, leucine) into nucleic acid and protein that was not attributable to impaired transport of these substrates into the cell after porphyrin treatment.
The L1210 cell has a permeability barrier to uptake of actinomycin D, which can be partially removed by detergent treatment (Kessel, 1976) . The rate of actinomycin D u p take was increased by 50% after treatment with deuteroporphyrin IX as outlined above. A similar increase in binding of the fluorogenic dye 8-anilinonaphthalene-lsulphonic acid was also observed. None of the effects described here was detected when L1210 cells were exposed to substantially higher (50-100p~) concentrations of porphyrin in the dark.
Further studies involved estimates of effects of photo-activated porphyrins on the negative charge at and near the cell surface. Partition of cells between the immiscible phases of a dextran/poly(ethyleneglycol) mixture containing sodium phosphate was measured. We found that exposure of L1210 cells to 3p~-deuteroporphyrin IX in the light decreased by 50 % the number of cells partitioning into the top phase, an indication that the membrane charge had significantly decreased (Albertsson, 1971 ; Walter, 1975) . Exposure to singlet oxygen therefore caused both a decrease in cell-surface charge and an increase in number of 8-anilinonaphthalene-1 -sulphonic acid binding sites; a correlation between these two phenomena has been cited before (Waggoner, 1976) .
VOl. 5 BIOCHEMICAL SOCIETY TRANSACTIONS
Exposure of L1210 cells to high (50-100p~) concentrations of photo-activated porphyrin caused interference with other cellular functions, namely a 50% inhibition in rate of monosaccharide uptake and a 40-50 % inhibition in activity of intracellular nucleoside kinases. Under these conditions, transport of nucleosides and cycloleucine was essentially abolished, the rate of actinomycin D uptake was increased to 300 %of control values and 8-anilinonaphthalene-1 -sulphonic acid binding was increased fourfold. But, surprisingly, fluorescence of the bound dye fell to control values, indicating a substantial decrease in fluorescence yield.
One determinant of fluorescence of bound 8-anilinonaphthalene-1 -sulphonic acid is the polarity of the environment (Stryer, 1968; Radda, 1975) . Altered hydrophobocity of cell components after exposure to high concentrations of singlet oxygen may account for the low fluorescence yield in the experiment described above.
Thedata described here showthat the most sensitive sites of singlet-oxygencytotoxicity involve the cell membrane and result in impaired nucleoside and amino acid transport, alteration in other permeability barriers and in surface charge. Only at substantially higher concentrations of photo-activated porphyrin, presumably resulting in formation of higher concentrations of singlet oxygen, do I find inhibition of intracellular biotransformations.
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